NTLA
Intellia Therapeutics, Inc. · Healthcare
EVP and CFO Edward J Dulac III sold $59K of Intellia Therapeutics, Inc.
Sold$58,751
$9.21Price
6,379Shares
−6%Stake
What NTLA did after the filing
- The stock from Wed, Jan 7 close, $10.13
- +24.8%
- S&P 500, same days
- 0.0%
Measured over 30 trading days, to the Feb 20 close.
Traded Mon, Jan 5. Filed Wed, Jan 7, 11:02 AM ET, during the session. Returns use the Jan 7 close and the Feb 20 close. Not investment advice.